BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Akitoshi Douhara, Tadashi Namisaki, Kei Moriya, Mitsuteru Kitade, Kosuke Kaji, Hideto Kawaratani, Kosuke Takeda, Yasushi Okura, Hiroaki Takaya, Ryuichi Noguchi, Norihisa Nishimura, Kenichiro Seki, Shinya Sato, Yasuhiko Sawada, Junichi Yamao, Akira Mitoro, Masakazu Uejima, Tsuyoshi Mashitani, Naotaka Shimozato, Soichiro Saikawa, Keisuke Nakanishi, Masanori Furukawa, Takuya Kubo, Hitoshi Yoshiji. Predisposing factors for hepatocellular carcinoma recurrence following initial remission after transcatheter arterial chemoembolizationOncology Letters 2017; 14(3): 3028 doi: 10.3892/ol.2017.6489
2
Shunichi Matsuoka, Hirotoshi Fujikawa, Hiromasa Hasegawa, Takanaga Ochiai, Yukinobu Watanabe, Mitsuhiko Moriyama. Onset of Tuberculosis from a Pulmonary Latent Tuberculosis Infection during Antiviral Triple Therapy for Chronic Hepatitis CInternal Medicine 2016; 55(15): 2011 doi: 10.2169/internalmedicine.55.6448
3
Francesca Romana Ponziani, Francesca Mangiola, Cecilia Binda, Maria Assunta Zocco, Massimo Siciliano, Antonio Grieco, Gian Lodovico Rapaccini, Maurizio Pompili, Antonio Gasbarrini. Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis CWorld Journal of Hepatology 2017; 9(7): 352-367 doi: 10.4254/wjh.v9.i7.352
4
Tarek K. Motawi, Olfat G. Shaker, Shohda A. El-Maraghy, Mahmoud A. Senousy, Anand S Mehta. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian PatientsPLOS ONE 2015; 10(9): e0137706 doi: 10.1371/journal.pone.0137706